| Liver transplantation in adult polycystic liver disease: the Ontario experience M Alsager, SF Neong, R Gandhi, A Teriaky, E Tang, A Skaro, K Qumosani, ... BMC gastroenterology 21, 1-6, 2021 | 14 | 2021 |
| Red blood cell alloimmunization in sickle cell disease patients in Jeddah, Saudi Arabia: a pilot study A Alboog, T Tayeb, M Alsager, S Alnajjar, G Damanhouri, J Jarullah, ... JKAU Med Sci 22 (3), 35-40, 2015 | 6 | 2015 |
| Sleep disturbances among medical students at clinical years M Alsaggaf, S Wali, M Alsager, A Bakhsh, R Alkhammash, E Quqandi European Respiratory Journal 44 (Suppl 58), 2014 | 6 | 2014 |
| Association of trainee participation in colonoscopy procedures with quality metrics M Sey, S Cocco, C McDonald, Z Hindi, H Rahman, D Chakraborty, ... JAMA Network Open 5 (8), e2229538-e2229538, 2022 | 2 | 2022 |
| P-148 use of patient to physician electronic communication differs among IBD patients based on patient age M Alsager, D Alsaadi, A Radhi, M Chandler, M Borum Inflammatory Bowel Diseases 23, S52, 2017 | 1 | 2017 |
| P-149 Make the First Visit Count: Health Literacy and Counselling Should Occur During the Initial IBD Encounter E Davis, S Taneja, A Khan, G Piech, M Alsager, M Borum Inflammatory Bowel Diseases 23 (suppl_1), S52-S52, 2017 | 1 | 2017 |
| ROLE OF NON-INVASIVE MARKERS IN ASSESSING THE DEGREE OF FIBROSIS IN AUTOIMMUNE HEPATITIS, PRIMARY BILIARY CHOLANGITIS, AND OVERLAP SYNDROME A CANADIAN MULTI-CENTER REVIEW M Alsager, SB Roberts, S Son, A Teriaky, N Selzner, M Cameron, ... HEPATOLOGY 78, S2021-S2023, 2023 | | 2023 |
| A93 IMPROVING INPATIENT ENDOSCOPY PROCEDURAL THROUGHPUT: A QUALITY IMPROVEMENT INITIATIVE AT AN ACADEMIC MEDICAL CENTER M Alsager, D Hudson, C Lavalle, V Iablokov, A Alajmi Journal of the Canadian Association of Gastroenterology 6 (Suppl 1), 50, 2023 | | 2023 |
| S1485 Increasing Inpatient Endoscopy Volumes Using the Model for Continuous Improvement D Hudson, Z Hindi, M Alsager, C Lavalle, A Alajmi, V Iablokov, J Gregor, ... Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022 | | 2022 |
| A218 THE RISK OF RECURRENT HEPATOCELLULAR CARDINOMA IN POST-LIVER TRANSPLANT PATIENTS RECEIVING CAPECITABINE TREATMENT M Alsager, V Chaitanya, R Gandhi, K Puka, E Tang, A Teriaky, ... Journal of the Canadian Association of Gastroenterology 5 (Suppl 1), 107, 2022 | | 2022 |
| A113 ANNUAL COLONOSCOPY VOLUME IS NOT PREDICTIVE OF COLONOSCOPY QUALITY-FINDINGS FROM THE SOUTHWEST ONTARIO COLONOSCOPY COHORT M Sey, O Siddiqi, C McDonald, S cocco, Z Hindi, H Rahman, ... Journal of the Canadian Association of Gastroenterology 4 (Supplement_1), 92-93, 2021 | | 2021 |
| LIVER TRANSPLANTATION IN ADULT POLYCYSTIC LIVER DISEASE: THE ONTARIO EXPERIENCE M Alsager, SF Neong, R Gandhi, A Teriaky, E Tang, AI Skaro, ... HEPATOLOGY 72, 819A-819A, 2020 | | 2020 |
| THE RISK OF RECURRENT HEPATOCELLULAR CARCINOMA IN POST-LIVER TRANSPLANT PATIENTS RECEIVING CAPECITABINE TREATMENT M Alsager, V Chaitanya, R Gandhi, K Puka, E Tang, A Teriaky, ... The Liver Meeting Digital Experience™, 2020 | | 2020 |
| P-160 African American IBD Patients Receive More PPSV23 Vaccinations than Non-African American IBD Patients A Khan, M Alsager, M Chandler, M Borum Inflammatory Bowel Diseases 23, S55-S56, 2017 | | 2017 |
| P-141 Do IBD Patients Need More Attention? An Analysis of Healthcare Utilization Among IBD Patients M Alsager, S Testa, A Radhi, M Chandler, M Borum Inflammatory Bowel Diseases 23 (suppl_1), S49-S50, 2017 | | 2017 |
| P-147 Health Literacy Assessments Infrequently Occur in Inflammatory Bowel Disease Patients Receiving Counselling About Biologic Therapy S Shah, S Taneja, A Khan, M Alsager, G Piech, M Borum Inflammatory Bowel Diseases 23 (suppl_1), S51-S51, 2017 | | 2017 |
| P-161 Physicians Infrequently Perform Health Literacy Assessments in IBD Patients Who Are Not Undergoing a Procedure J Friedman, S Taneja, R Mara, A Khan, M Alsager, G Piech, M Borum Inflammatory Bowel Diseases 23 (suppl_1), S56-S56, 2017 | | 2017 |
| P-175 Physicians Inadequately Counsel IBD Patients About the Risks Associated with Live Vaccines Prior to or During Immunosuppressant and Biologic Therapy A Radhi, M Alsager, M Chandler, M Borum Inflammatory Bowel Diseases 23, S59, 2017 | | 2017 |
| P-176 Physicians Inadequately Address Infectious Risks Associated with Travel in IBD Patients A Radhi, M Alsager, D Alsaadi, M Chandler, M Borum Inflammatory Bowel Diseases 23, S59-S60, 2017 | | 2017 |
| P-174 Greater TB and Hepatitis B Screenings Among IBD Patients on Dual Therapies than Those on Immunosuppressive Monotherapy A Khan, M Alsager, M Chandler, M Borum Inflammatory Bowel Diseases 23 (suppl_1), S59-S59, 2017 | | 2017 |
